| abstract |
Methods for treating, inhibiting or ameliorating an auto-inflammatory condition, disease or condition in a subject in need thereof are described, wherein the methods comprise administering to a subject in need a therapeutic amount of an interleukin 1 antagonist (IL-1). , where the disease, disease or auto-inflammatory condition is treated, inhibited or reduced. The IL-1 antagonist is a molecule with the ability to bind and inhibit IL-1. Therapeutic methods with tools to treat an adult or human child suffering from Neonatal Generation Multisystem Disease (NOM ID / CINCA), Muckle-Wels Syndrome (MWS), Family Cold Autoinflammatory Syndrome (FCAS), family Mediterranean fever ( FMF), periodic fever syndrome associated with tumor necrosis factor receptor (TRAPS) or systemic generation juvenile idiomatic arthritis (Still's Disease). |